Please login to the form below
Learner Adams Bones
This page shows the latest Learner Adams Bones news and features for those working in and with pharma, biotech and healthcare.
PMEA 2020: continuing to recognise excellence in improving patient outcomes
with support from Learner Adams Bones Ltd. 8. Excellence in Rare Diseases and Orphan Drugs.
Latest news
-
Havas Lynx excels at PM Society Awards
Craft Award for Disease Awareness - Havas Lynx . Craft Award for Patient Support - Learner Adams Bones for AbbVie.
-
VCCP Health and Havas Life Medicom tie for first at PM Society Awards
Target Award for Secondary Care Ad - Learner Adams Bones for Takeda UK. •
-
Europe sans frontiers...
customisation'. Gill Adams, managing director, Learner Adams Bones. Recently my mother, a pharmacist, was explaining to a friend what our agency does.
-
Let's explore
Selwyn Learner and Ed Bones take us on a journey of discovery. ... The Authors. Selwyn Learner(left) and Ed Bones (right) are co-founders and creative directors ofTo comment on this article, email pm@pmlive.com.
More from news
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Learner Adams Bones
Learner Adams Bones.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Rare diseases: not so rare after all
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- NHS England announces rare genetic disorder fast-tracking service
- NICE sees ‘promise’ in four UTI tests that could help in fight against AMR
- Connectome competitiveness
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- Sobi’s Kineret granted FDA Emergency Use Authorisation for COVID-19 related pneumonia
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
